Health & Environmental Research Online (HERO)


Print Feedback Export to File
7064227 
Journal Article 
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery 
Legg, LA; Tilney, R; Hsieh, CF; Wu, S; Lundström, E; Rudberg, AS; Kutlubaev, MA; Dennis, M; Soleimani, B; Barugh, A; Hackett, ML; Hankey, GJ; Mead, GE; , 
2019 
Yes 
Cochrane Database of Systematic Reviews
ISSN: 1469-493X 
WILEY 
HOBOKEN 
English 
31769878 
WOS:000504427100035 
Stroke is a major cause of adult disability. Selective serotonin reuptake inhibitors (SSRIs) have been used for many years to manage depression and other mood disorders after stroke. The 2012 Cochrane Review of SSRIs for stroke recovery demonstrated positive effects on recovery, even in people who were not depressed at randomisation. A large trial of fluoxetine for stroke recovery (fluoxetine versus placebo under supervision) has recently been published, and it is now appropriate to update the evidence.